US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acumen Pharmaceuticals, Inc.

1.06

+0.159217.67%

Post-market: 1.04-0.0199-1.88%19:56 EDT

Volume:387.89K

Turnover:371.31K

Market Cap:64.21M

PE:-0.62

High:1.07

Open:0.8700

Low:0.8551

Close:0.9008

Loading ...

Overview Company News Filings

BRIEF-Acumen Pharmaceuticals To Report Fourth Quarter And Year-End 2024 Financial Results On March 27, 2025

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

THOMSON REUTERS

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Acumen Pharmaceuticals Announces Topline Results From Phase 1 Study of Subcutaneous Formulation of Sabirnetug in Healthy Volunteers

THOMSON REUTERS

Acumen Pharmaceuticals Inc - Weekly Sc Administration of Sabirnetug Well-Tolerated

THOMSON REUTERS

Acumen Pharmaceuticals Inc - Phase 2 Altitude-Ad Study of Iv Sabirnetug Ongoing

THOMSON REUTERS

Acumen Pharmaceuticals Announces Topline Results from Phase 1 Study of Subcutaneous Formulation of Sabirnetug in Healthy Volunteers

Acumen Pharmaceuticals CEO Discusses Novel Targeted Therapies for Alzheimer’s

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

Promising US Penny Stocks To Consider In January 2025

Simply Wall St.

Acumen announces Phase 1 INTERCEPT-AD study publication

Acumen Pharmaceuticals Announces Journal of Prevention of Alzheimer’s Disease Publication of the Company’s Phase 1 INTERCEPT-AD Study, Including Target Engagement, Dosing Regimen and Safety Findings

Analysts Offer Insights on Healthcare Companies: Acumen Pharmaceuticals (ABOS) and Immix Biopharma, Inc. (IMMX)

I-Mab Leads Our Spotlight On 3 US Penny Stocks

Simply Wall St.

Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Acumen Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $12 From $14

THOMSON REUTERS

Bank of America Securities Keeps Their Buy Rating on Acumen Pharmaceuticals (ABOS)

Acumen Pharmaceuticals Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Acumen Pharmaceuticals Inc (ABOS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...

Q3 2024 Acumen Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ABOS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABOS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABOS\",,,,,undefined,":{"symbol":"ABOS","market":"US","secType":"STK","nameCN":"Acumen Pharmaceuticals, Inc.","latestPrice":1.06,"timestamp":1745265600000,"preClose":0.9008,"halted":0,"volume":387885,"hourTrading":{"tag":"盘后","latestPrice":1.0401,"preClose":1.06,"latestTime":"19:56 EDT","volume":16941,"amount":19004.6615,"timestamp":1745279801820},"delay":0,"floatShares":32929494,"shares":60573425,"eps":-1.705106,"marketStatus":"Not Yet Opened","change":0.1592,"latestTime":"04-21 16:00:00 EDT","open":0.87,"high":1.07,"low":0.8551,"amount":371308.78882889997,"amplitude":0.238566,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.705106,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":0,"adr":0,"listingDate":1625112000000,"exchange":"NASDAQ","adjPreClose":0.9008,"postHourTrading":{"tag":"盘后","latestPrice":1.0401,"preClose":1.06,"latestTime":"19:56 EDT","volume":16941,"amount":19004.6615,"timestamp":1745279801820},"volumeRatio":1.577501,"impliedVol":0.6471,"impliedVolPercentile":0.32},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABOS\",,,,,undefined,":{"symbol":"ABOS","floatShares":32929494,"roa":"-25.95%","roe":"-45.60%","lyrEps":-1.705106,"volumeRatio":1.577501,"shares":60573425,"dividePrice":0,"high":1.07,"amplitude":0.238566,"preClose":0.9008,"low":0.8551,"week52Low":0.8551,"pbRate":"0.35","week52High":3.92,"institutionHeld":0,"latestPrice":1.06,"eps":-1.705106,"divideRate":0,"volume":387885,"delay":0,"ttmEps":-1.705106,"open":0.87,"prevYearClose":1.72,"prevWeekClose":0.9008,"prevMonthClose":1.1,"prevQuarterClose":1.1,"fiveDayClose":1.11,"twentyDayClose":1.2,"sixtyDayClose":1.73},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABOS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521919494","title":"BRIEF-Acumen Pharmaceuticals To Report Fourth Quarter And Year-End 2024 Financial Results On March 27, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2521919494","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521919494?lang=en_us&edition=fundamental","pubTime":"2025-03-21 04:43","pubTimestamp":1742503389,"startTime":"0","endTime":"0","summary":"BRIEF-Acumen Pharmaceuticals To Report Fourth Quarter And Year-End 2024 Financial Results On March 27, 2025March 20 (Reuters) - Acumen Pharmaceuticals Inc ABOS.O:ACUMEN PHARMACEUTICALS TO REPORT FOURT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA137S5L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","ABOS"],"gpt_icon":0},{"id":"2521496333","title":"Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2521496333","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521496333?lang=en_us&edition=fundamental","pubTime":"2025-03-21 04:00","pubTimestamp":1742500801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA137S5L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABOS","BK4539","BK4139"],"gpt_icon":0},{"id":"2521549667","title":"Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2521549667","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521549667?lang=en_us&edition=fundamental","pubTime":"2025-03-21 04:00","pubTimestamp":1742500800,"startTime":"0","endTime":"0","summary":"NEWTON, Mass., March  20, 2025  (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/20/3046680/0/en/Acumen-Pharmaceuticals-to-Report-Fourth-Quarter-and-Year-End-2024-Financial-Results-on-March-27-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABOS","BK4539"],"gpt_icon":0},{"id":"2520918876","title":"Acumen Pharmaceuticals Announces Topline Results From Phase 1 Study of Subcutaneous Formulation of Sabirnetug in Healthy Volunteers","url":"https://stock-news.laohu8.com/highlight/detail?id=2520918876","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520918876?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:00","pubTimestamp":1742385601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nTUA7PNSFK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","ABOS"],"gpt_icon":0},{"id":"2520712188","title":"Acumen Pharmaceuticals Inc - Weekly Sc Administration of Sabirnetug Well-Tolerated","url":"https://stock-news.laohu8.com/highlight/detail?id=2520712188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520712188?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:00","pubTimestamp":1742385601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nTUA7PNSFK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","ABOS"],"gpt_icon":0},{"id":"2520188732","title":"Acumen Pharmaceuticals Inc - Phase 2 Altitude-Ad Study of Iv Sabirnetug Ongoing","url":"https://stock-news.laohu8.com/highlight/detail?id=2520188732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520188732?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:00","pubTimestamp":1742385601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nTUA7PNSFK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ABOS","BK4139"],"gpt_icon":0},{"id":"2520185769","title":"Acumen Pharmaceuticals Announces Topline Results from Phase 1 Study of Subcutaneous Formulation of Sabirnetug in Healthy Volunteers","url":"https://stock-news.laohu8.com/highlight/detail?id=2520185769","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520185769?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:00","pubTimestamp":1742385600,"startTime":"0","endTime":"0","summary":"Weekly subcutaneous administration of sabirnetug was well-tolerated in the Phase 1 study. Systemic exposure following subcutaneous administration supports further clinical development. Development of sabirnetug delivered subcutaneously has the potential for decreased treatment burden and increased patient convenience. Sabirnetug is the first humanized monoclonal antibody to clinically demonstrate selective target engagement of AβOs in patients with AD. The SC formulation of sabirnetug is co-formulated with Halozyme’s proprietary ENHANZE drug delivery technology  that enables large volume SC injection with increased dispersion and absorption of co-administered therapies. ENHANZE has been commercially validated as a component of nine approved therapies.Sabirnetug  is a humanized monoclonal antibody  discovered and developed based on its selectivity for soluble amyloid beta oligomers , which are a highly toxic and pathogenic form of Aβ, relative to Aβ monomers and amyloid plaques. Soluble","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acumen-pharmaceuticals-announces-topline-results-120000503.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4181","BK4539","ABOS","BK4139","PK","BK4218"],"gpt_icon":0},{"id":"2520679021","title":"Acumen Pharmaceuticals CEO Discusses Novel Targeted Therapies for Alzheimer’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2520679021","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520679021?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:48","pubTimestamp":1742302080,"startTime":"0","endTime":"0","summary":"NEW YORK, March 18, 2025  -- Today's Marketplace  is proud to announce a featured interview with Acumen Pharmaceuticals  CEO Daniel O’Connell and Jessica Clark, DNP, RN, Dean of the College of Nursing at Creighton University. The pair joined Today’s Marketplace host Elizabeth Hart to discuss Alzheimer’s Disease.The full interview can be viewed online here.“In the U.S., we have over six million people diagnosed with active Alzheimer’s today, and worldwide, about 55 million,” said Clark.Dr. Clark went on to say that the economic impact of this devastating disease could seem “insurmountable at times,” explaining that the treatment and long-term care costs associated with Alzheimer's are about $360 billion dollars. And that does not even consider the time investment and productivity losses experienced by caregivers.Acumen Pharmaceuticals is a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers  for the treatment of Alzhe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acumen-pharmaceuticals-ceo-discusses-novel-124800149.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4211","BK4539","ABOS","BK4139","NYSE","TMP"],"gpt_icon":0},{"id":"2518620036","title":"Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2518620036","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518620036?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:00","pubTimestamp":1741636800,"startTime":"0","endTime":"0","summary":"NEWTON, Mass., March  10, 2025  (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble am","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/10/3040126/0/en/Acumen-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ABOS","BK4139"],"gpt_icon":0},{"id":"2506818855","title":"Promising US Penny Stocks To Consider In January 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2506818855","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506818855?lang=en_us&edition=fundamental","pubTime":"2025-01-25 04:10","pubTimestamp":1737749404,"startTime":"0","endTime":"0","summary":"As the U.S. equities market takes a breather from its recent rally, major indexes have slipped slightly after reaching record high levels. In this context, penny stocks—often associated with smaller or newer companies—continue to offer intriguing growth opportunities at lower price points. Despite being considered a somewhat outdated term, these stocks can still provide significant potential when backed by strong financials and fundamentals.Overview: Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for Alzheimer's disease, with a market cap of approximately $105.14 million.Jump into the full analysis health report here for a deeper understanding of Acumen Pharmaceuticals.Gain insights into Acumen Pharmaceuticals' future direction by reviewing our growth report.Overview: Sight Sciences, Inc. is an ophthalmic medical device company focused on developing and commercializing surgical and nonsurgical technologies for treatin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/promising-us-penny-stocks-consider-201004884.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4209","SGHT","BABB","BK4082","ABOS","BK4139","VGZ"],"gpt_icon":0},{"id":"2502014955","title":"Acumen announces Phase 1 INTERCEPT-AD study publication","url":"https://stock-news.laohu8.com/highlight/detail?id=2502014955","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502014955?lang=en_us&edition=fundamental","pubTime":"2025-01-09 21:05","pubTimestamp":1736427912,"startTime":"0","endTime":"0","summary":"Acumen (ABOS) Pharmaceuticals announced that the Journal of Prevention of Alzheimer’s Disease published the results of the Phase 1 INTERCEPT-AD cli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acumen-announces-phase-1-intercept-ad-study-publication?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acumen-announces-phase-1-intercept-ad-study-publication?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","ABOS"],"gpt_icon":0},{"id":"2502011140","title":"Acumen Pharmaceuticals Announces Journal of Prevention of Alzheimer’s Disease Publication of the Company’s Phase 1 INTERCEPT-AD Study, Including Target Engagement, Dosing Regimen and Safety Findings","url":"https://stock-news.laohu8.com/highlight/detail?id=2502011140","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502011140?lang=en_us&edition=fundamental","pubTime":"2025-01-09 21:00","pubTimestamp":1736427600,"startTime":"0","endTime":"0","summary":"Phase 1 INTERCEPT-AD data published in Journal of Prevention of Alzheimer’s Disease supports continued development of sabirnetug (ACU193) for treatment of early Alzheimer’s disease (AD) Sabirnetug dem","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/09/3007016/0/en/Acumen-Pharmaceuticals-Announces-Journal-of-Prevention-of-Alzheimer-s-Disease-Publication-of-the-Company-s-Phase-1-INTERCEPT-AD-Study-Including-Target-Engagement-Dosing-Regimen-and.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PK","BK4181","BK4539","BK4218","ARIA","ABOS"],"gpt_icon":0},{"id":"2501287201","title":"Analysts Offer Insights on Healthcare Companies: Acumen Pharmaceuticals (ABOS) and Immix Biopharma, Inc. (IMMX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2501287201","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501287201?lang=en_us&edition=fundamental","pubTime":"2025-01-06 19:30","pubTimestamp":1736163008,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Acumen Pharmaceuticals (ABOS – Research Report) and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-acumen-pharmaceuticals-abos-and-immix-biopharma-inc-immx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-acumen-pharmaceuticals-abos-and-immix-biopharma-inc-immx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMMX","ABOS","BK4137","BK4539","BK4139","HCSG"],"gpt_icon":0},{"id":"2489128591","title":"I-Mab Leads Our Spotlight On 3 US Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2489128591","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489128591?lang=en_us&edition=fundamental","pubTime":"2024-12-04 21:04","pubTimestamp":1733317489,"startTime":"0","endTime":"0","summary":"As the S&P 500 and Nasdaq hit record highs, the U.S. stock market continues its post-election rally with optimism among investors. Amidst this backdrop, penny stocks remain a fascinating segment of the market, often representing smaller or newer companies that can offer unique opportunities for growth. While the term 'penny stocks' might seem outdated, they still hold relevance for those looking to explore investments beyond established giants; here we spotlight three such stocks that stand...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-abos/acumen-pharmaceuticals/news/i-mab-leads-our-spotlight-on-3-us-penny-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4539","PETS","BK4209","BK4526","BK4200","BK4563","BK4021","BABB","BK4551","BK4139","ABOS","BK4122","SB","RLX","BK4075"],"gpt_icon":0},{"id":"2486122831","title":"Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2486122831","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486122831?lang=en_us&edition=fundamental","pubTime":"2024-11-27 05:00","pubTimestamp":1732654800,"startTime":"0","endTime":"0","summary":"NEWTON, Mass., Nov.  26, 2024  (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amy","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/26/2987797/0/en/Acumen-Pharmaceuticals-to-Participate-in-the-7th-Annual-Evercore-ISI-HealthCONx-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0},{"id":"2483088737","title":"Acumen Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $12 From $14","url":"https://stock-news.laohu8.com/highlight/detail?id=2483088737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483088737?lang=en_us&edition=fundamental","pubTime":"2024-11-13 23:14","pubTimestamp":1731510881,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nFWN3MK2H2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABOS","BK4539","BK4139"],"gpt_icon":0},{"id":"2483988280","title":"Bank of America Securities Keeps Their Buy Rating on Acumen Pharmaceuticals (ABOS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483988280","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483988280?lang=en_us&edition=fundamental","pubTime":"2024-11-13 22:56","pubTimestamp":1731509808,"startTime":"0","endTime":"0","summary":"In a report released today, Jason Zemansky from Bank of America Securities maintained a Buy rating on Acumen Pharmaceuticals (ABOS – Research Repor...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-keeps-their-buy-rating-on-acumen-pharmaceuticals-abos?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-keeps-their-buy-rating-on-acumen-pharmaceuticals-abos?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABOS"],"gpt_icon":0},{"id":"2483881793","title":"Acumen Pharmaceuticals Price Target Maintained With a $15.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2483881793","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483881793?lang=en_us&edition=fundamental","pubTime":"2024-11-13 22:47","pubTimestamp":1731509220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABOS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 13, 2024 09:47 ET (14:47 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS"],"gpt_icon":0},{"id":"2483026814","title":"Acumen Pharmaceuticals Inc (ABOS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2483026814","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483026814?lang=en_us&edition=fundamental","pubTime":"2024-11-13 15:06","pubTimestamp":1731481597,"startTime":"0","endTime":"0","summary":"Cash and Marketable Securities: $259 million as of September 30, 2024.Cash Runway: Expected to last into the first half of 2027.R&D Expenses: $27.2 million in the third quarter.G&A Expenses: $5 million in the third quarter.Loss from Operations: $32.3 million in the third quarter.Net Loss: $29.8 million in the third quarter.Net Cash: Approximately $23 million in the third quarter.Net Interest Income: $2.5 million in the third quarter.Noncash Stock Compensation Expense: $2.4 million in the third quarter.GuruFocus has detected 2 Warning Signs with ABOS.Acumen Pharmaceuticals Inc  has a strong cash position with approximately $259 million in cash and marketable securities, expected to last into the first half of 2027.The Alzheimer's treatment field is highly competitive, and while Acumen Pharmaceuticals Inc  is positioned well, it faces challenges from other anti-amyloid treatments.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acumen-pharmaceuticals-inc-abos-q3-070637047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ABOS"],"gpt_icon":0},{"id":"2483483340","title":"Q3 2024 Acumen Pharmaceuticals Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2483483340","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483483340?lang=en_us&edition=fundamental","pubTime":"2024-11-13 11:54","pubTimestamp":1731470087,"startTime":"0","endTime":"0","summary":"Daniel O'Connell; Chief Executive Officer, Director; Acumen Pharmaceuticals Inc. W. Matthew Zuga; Chief Financial Officer, Chief Business Officer; Acumen Pharmaceuticals Inc. James Doherty; President, Chief Development Officer; Acumen Pharmaceuticals Inc. Eric Siemers; Chief Medical Officer; Acumen Pharmaceuticals Inc. Hello, and welcome to Acumen Pharmaceuticals Q3 2024 conference call and webcast. At this time, all participants are in a listen-only mode. As of the speaker's presentation, there will be a question-and-answer session.  I would now like to hand the conference over to Alex Braun. You may begin.Thanks, Alex. Good morning, everyone, and thanks for joining us today. The third quarter was one of focused execution as we continue to progress our clinical efforts for sabirnetug, our next-generation amyloid beta oligomer-targeted antibody for the treatment of early Alzheimer's disease. ALTITUDE AD, our Phase 2 study designed to evaluate the clinical efficacy and safety of subunit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q3-2024-acumen-pharmaceuticals-inc-035447852.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ABOS"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":56,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABOS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-27","symbol":"ABOS","fiscalQuarterEnding":"2024/12","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.62},{"market":"US","date":"2024-11-12","symbol":"ABOS","fiscalQuarterEnding":"2024/09","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.5},{"market":"US","date":"2024-08-13","symbol":"ABOS","fiscalQuarterEnding":"2024/06","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2024-05-14","symbol":"ABOS","fiscalQuarterEnding":"2024/03","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"pre","actualEps":-0.25},{"market":"US","date":"2024-03-26","symbol":"ABOS","fiscalQuarterEnding":"2023/12","expectedEps":-0.29,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1711425600000,"reportTimeType":"pre","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABOS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABOS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":6,"updateTime":1702353600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ABOS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ABOS","date":"2025-04-17","current":-0.580109,"percent":0.997831,"low":-24.285355,"twenty":-6.515538,"median":-3.829108,"eighty":-2.181634,"high":-0.576676,"avg":-4.729333,"sd":3.82612,"marketCap":59361956},"quantilePoints":[{"date":"2021-07-02","current":-24.285355,"twenty":-23.282602,"median":-17.962584,"eighty":-17.962584,"marketCap":783858402},{"date":"2021-07-09","current":-22.632801,"twenty":-23.49497,"median":-22.453176,"eighty":-17.962584,"marketCap":730518925},{"date":"2021-07-16","current":-21.387398,"twenty":-22.821186,"median":-22.058,"eighty":-19.615112,"marketCap":690321058},{"date":"2021-07-23","current":-20.453346,"twenty":-22.762131,"median":-21.9622,"eighty":-20.489271,"marketCap":660172658},{"date":"2021-07-30","current":-18.537342,"twenty":-22.651961,"median":-21.004198,"eighty":-18.192479,"marketCap":598329786},{"date":"2021-08-06","current":-17.974516,"twenty":-22.525026,"median":-20.513221,"eighty":-17.962584,"marketCap":580163442},{"date":"2021-08-13","current":-18.166116,"twenty":-22.280735,"median":-19.189981,"eighty":-17.931406,"marketCap":586347730},{"date":"2021-08-20","current":-7.634154,"twenty":-22.15859,"median":-18.285866,"eighty":-17.71346,"marketCap":699288543},{"date":"2021-08-27","current":-8.252662,"twenty":-22.03884,"median":-17.992479,"eighty":-8.058274,"marketCap":755943865},{"date":"2021-09-03","current":-6.887527,"twenty":-21.617319,"median":-17.962584,"eighty":-7.680984,"marketCap":630897476},{"date":"2021-09-10","current":-7.510453,"twenty":-21.349078,"median":-17.950566,"eighty":-7.666847,"marketCap":687957479},{"date":"2021-09-17","current":-7.170273,"twenty":-21.061678,"median":-17.84279,"eighty":-7.521056,"marketCap":656797052},{"date":"2021-09-24","current":-7.130512,"twenty":-20.654527,"median":-17.663165,"eighty":-7.137581,"marketCap":653154924},{"date":"2021-10-01","current":-6.746154,"twenty":-20.541962,"median":-12.845778,"eighty":-7.060709,"marketCap":617947688},{"date":"2021-10-08","current":-5.942094,"twenty":-20.489271,"median":-8.093617,"eighty":-6.829211,"marketCap":544295770},{"date":"2021-10-15","current":-5.986273,"twenty":-20.209056,"median":-7.868304,"eighty":-6.749688,"marketCap":548342578},{"date":"2021-10-22","current":-6.35296,"twenty":-19.320509,"median":-7.709259,"eighty":-6.596828,"marketCap":581931091},{"date":"2021-10-29","current":-6.207168,"twenty":-18.460702,"median":-7.618691,"eighty":-6.547348,"marketCap":568576622},{"date":"2021-11-05","current":-6.573855,"twenty":-18.321792,"median":-7.510453,"eighty":-6.499634,"marketCap":602165134},{"date":"2021-11-12","current":-5.721198,"twenty":-18.237966,"median":-7.159228,"eighty":-6.436016,"marketCap":524061726},{"date":"2021-11-19","current":-4.290171,"twenty":-18.103846,"median":-7.121676,"eighty":-6.359144,"marketCap":399037384},{"date":"2021-11-26","current":-3.598348,"twenty":-18.003256,"median":-7.081915,"eighty":-6.245163,"marketCap":334689571},{"date":"2021-12-03","current":-3.398198,"twenty":-17.97213,"median":-6.960422,"eighty":-6.12853,"marketCap":316073222},{"date":"2021-12-10","current":-3.063165,"twenty":-17.962584,"median":-6.808005,"eighty":-5.947395,"marketCap":284911073},{"date":"2021-12-17","current":-2.993547,"twenty":-17.962584,"median":-6.759408,"eighty":-5.733568,"marketCap":278435822},{"date":"2021-12-23","current":-3.076218,"twenty":-17.962584,"median":-6.746154,"eighty":-4.668715,"marketCap":286125183},{"date":"2021-12-31","current":-2.941334,"twenty":-17.950566,"median":-6.693139,"eighty":-3.915978,"marketCap":273579383},{"date":"2022-01-07","current":-2.501875,"twenty":-17.902666,"median":-6.569437,"eighty":-3.533082,"marketCap":232704357},{"date":"2022-01-14","current":-2.340884,"twenty":-17.84279,"median":-6.560601,"eighty":-3.298123,"marketCap":217730337},{"date":"2022-01-21","current":-2.253863,"twenty":-17.84279,"median":-6.529676,"eighty":-3.128431,"marketCap":209636273},{"date":"2022-01-28","current":-2.179894,"twenty":-17.76615,"median":-6.50096,"eighty":-3.056203,"marketCap":202756318},{"date":"2022-02-04","current":-2.166841,"twenty":-17.67993,"median":-6.441318,"eighty":-3.000509,"marketCap":201542208},{"date":"2022-02-11","current":-2.345235,"twenty":-17.567365,"median":-6.368422,"eighty":-2.938723,"marketCap":218135040},{"date":"2022-02-18","current":-2.571492,"twenty":-17.399714,"median":-6.357377,"eighty":-2.830816,"marketCap":239179608},{"date":"2022-02-25","current":-2.488821,"twenty":-11.942176,"median":-6.255765,"eighty":-2.557568,"marketCap":231490247},{"date":"2022-03-04","current":-2.184245,"twenty":-8.282704,"median":-6.180661,"eighty":-2.531462,"marketCap":203161021},{"date":"2022-03-11","current":-2.397448,"twenty":-8.157235,"median":-6.127646,"eighty":-2.498394,"marketCap":222991479},{"date":"2022-03-18","current":-2.789046,"twenty":-8.090966,"median":-5.966392,"eighty":-2.491432,"marketCap":259414770},{"date":"2022-03-25","current":-2.236458,"twenty":-7.98582,"median":-5.942094,"eighty":-2.48534,"marketCap":208017460},{"date":"2022-04-01","current":-1.613202,"twenty":-7.858585,"median":-5.752123,"eighty":-2.459234,"marketCap":162297812},{"date":"2022-04-08","current":-1.609179,"twenty":-7.787898,"median":-4.68612,"eighty":-2.395708,"marketCap":161893080},{"date":"2022-04-14","current":-1.59711,"twenty":-7.743719,"median":-4.477268,"eighty":-2.375693,"marketCap":160678881},{"date":"2022-04-22","current":-1.653432,"twenty":-7.680984,"median":-4.068266,"eighty":-2.340884,"marketCap":166345139},{"date":"2022-04-29","current":-1.55375,"twenty":-7.636805,"median":-3.598348,"eighty":-2.293893,"marketCap":156316536},{"date":"2022-05-06","current":-1.465194,"twenty":-7.621784,"median":-3.48522,"eighty":-2.261695,"marketCap":147407303},{"date":"2022-05-13","current":-1.340411,"twenty":-7.576721,"median":-3.311177,"eighty":-2.229496,"marketCap":134853384},{"date":"2022-05-20","current":-1.703502,"twenty":-7.526357,"median":-3.263314,"eighty":-2.181634,"marketCap":140944377},{"date":"2022-05-27","current":-1.742663,"twenty":-7.455671,"median":-3.076218,"eighty":-2.166841,"marketCap":144184478},{"date":"2022-06-03","current":-1.801405,"twenty":-7.332853,"median":-3.063165,"eighty":-1.916589,"marketCap":149044629},{"date":"2022-06-10","current":-1.879727,"twenty":-7.165855,"median":-3.024005,"eighty":-1.875701,"marketCap":155524830},{"date":"2022-06-17","current":-1.61539,"twenty":-7.14465,"median":-3.002249,"eighty":-1.786719,"marketCap":133654151},{"date":"2022-06-24","current":-1.835671,"twenty":-7.130512,"median":-2.971792,"eighty":-1.762051,"marketCap":151879717},{"date":"2022-07-01","current":-2.305602,"twenty":-7.121676,"median":-2.934807,"eighty":-1.786719,"marketCap":190760925},{"date":"2022-07-08","current":-2.932178,"twenty":-7.093402,"median":-2.93023,"eighty":-1.786719,"marketCap":242602535},{"date":"2022-07-15","current":-3.079032,"twenty":-7.082799,"median":-2.928281,"eighty":-1.798468,"marketCap":254752912},{"date":"2022-07-22","current":-3.074136,"twenty":-7.053641,"median":-2.93023,"eighty":-1.805321,"marketCap":254347900},{"date":"2022-07-29","current":-2.662946,"twenty":-7.035969,"median":-2.893472,"eighty":-1.8063,"marketCap":220326843},{"date":"2022-08-05","current":-2.555254,"twenty":-6.916685,"median":-2.888122,"eighty":-1.829797,"marketCap":211416566},{"date":"2022-08-12","current":-2.643366,"twenty":-6.866321,"median":-2.848961,"eighty":-1.866889,"marketCap":218706793},{"date":"2022-08-19","current":-6.140146,"twenty":-6.966193,"median":-2.888122,"eighty":-1.87872,"marketCap":193604932},{"date":"2022-08-26","current":-7.052176,"twenty":-7.035969,"median":-2.893472,"eighty":-1.891475,"marketCap":222362150},{"date":"2022-09-02","current":-7.411849,"twenty":-7.058124,"median":-2.93023,"eighty":-1.921825,"marketCap":233703025},{"date":"2022-09-09","current":-8.657862,"twenty":-7.09585,"median":-2.939203,"eighty":-1.943364,"marketCap":272991055},{"date":"2022-09-16","current":-7.052176,"twenty":-7.137581,"median":-2.966444,"eighty":-1.985462,"marketCap":222362150},{"date":"2022-09-23","current":-5.947463,"twenty":-7.12521,"median":-2.997898,"eighty":-2.053302,"marketCap":187529464},{"date":"2022-09-30","current":-12.884029,"twenty":-7.15702,"median":-3.015395,"eighty":-2.099834,"marketCap":406246333},{"date":"2022-10-07","current":-12.614274,"twenty":-7.388838,"median":-3.045761,"eighty":-2.133486,"marketCap":397740677},{"date":"2022-10-14","current":-10.160785,"twenty":-7.596303,"median":-3.064346,"eighty":-2.159688,"marketCap":320379710},{"date":"2022-10-21","current":-9.813957,"twenty":-7.732232,"median":-3.076218,"eighty":-2.166841,"marketCap":309443867},{"date":"2022-10-28","current":-9.197373,"twenty":-7.820986,"median":-3.141484,"eighty":-2.166841,"marketCap":290002367},{"date":"2022-11-04","current":-8.169734,"twenty":-8.037325,"median":-3.289421,"eighty":-2.169452,"marketCap":257599868},{"date":"2022-11-11","current":-8.734935,"twenty":-8.202905,"median":-3.398198,"eighty":-2.176413,"marketCap":275421243},{"date":"2022-11-18","current":-6.490146,"twenty":-8.124064,"median":-3.535258,"eighty":-2.182505,"marketCap":248825726},{"date":"2022-11-25","current":-6.607567,"twenty":-8.09185,"median":-3.757163,"eighty":-2.187726,"marketCap":253327507},{"date":"2022-12-02","current":-5.977767,"twenty":-8.054616,"median":-4.220554,"eighty":-2.201649,"marketCap":229181590},{"date":"2022-12-09","current":-6.532845,"twenty":-7.992466,"median":-4.572991,"eighty":-2.219924,"marketCap":250462738},{"date":"2022-12-16","current":-6.105861,"twenty":-7.961637,"median":-5.156037,"eighty":-2.229496,"marketCap":234092624},{"date":"2022-12-23","current":-5.561458,"twenty":-7.929869,"median":-5.598819,"eighty":-2.233847,"marketCap":213220729},{"date":"2022-12-30","current":-5.764275,"twenty":-7.898102,"median":-5.598819,"eighty":-2.239939,"marketCap":220996533},{"date":"2023-01-06","current":-5.593482,"twenty":-7.822905,"median":-5.620168,"eighty":-2.253863,"marketCap":214448488},{"date":"2023-01-13","current":-6.66094,"twenty":-7.819707,"median":-5.703399,"eighty":-2.258214,"marketCap":255373772},{"date":"2023-01-20","current":-6.105861,"twenty":-7.811989,"median":-5.732251,"eighty":-2.265176,"marketCap":234092624},{"date":"2023-01-27","current":-5.817648,"twenty":-7.77923,"median":-5.773662,"eighty":-2.270397,"marketCap":223042797},{"date":"2023-02-03","current":-6.137885,"twenty":-7.767658,"median":-5.817648,"eighty":-2.274748,"marketCap":235320383},{"date":"2023-02-10","current":-6.084512,"twenty":-7.720746,"median":-5.860346,"eighty":-2.28606,"marketCap":233274118},{"date":"2023-02-17","current":-5.881695,"twenty":-7.652709,"median":-5.881695,"eighty":-2.2983,"marketCap":225498314},{"date":"2023-02-24","current":-5.593482,"twenty":-7.635921,"median":-5.838997,"eighty":-2.301318,"marketCap":214448488},{"date":"2023-03-03","current":-5.582807,"twenty":-7.615599,"median":-5.817648,"eighty":-2.301725,"marketCap":214039235},{"date":"2023-03-10","current":-4.86761,"twenty":-7.596303,"median":-5.817648,"eighty":-2.304051,"marketCap":186619295},{"date":"2023-03-17","current":-4.131064,"twenty":-7.55885,"median":-5.764275,"eighty":-2.311108,"marketCap":158380849},{"date":"2023-03-24","current":-4.184437,"twenty":-7.521056,"median":-5.732251,"eighty":-2.321021,"marketCap":160427113},{"date":"2023-03-31","current":-3.886544,"twenty":-7.451291,"median":-5.696476,"eighty":-2.334604,"marketCap":166561751},{"date":"2023-04-06","current":-3.656798,"twenty":-7.396509,"median":-5.678878,"eighty":-2.340884,"marketCap":156715736},{"date":"2023-04-14","current":-3.714235,"twenty":-7.347733,"median":-5.63618,"eighty":-2.342624,"marketCap":159177240},{"date":"2023-04-21","current":-3.829108,"twenty":-7.288533,"median":-5.625505,"eighty":-2.346976,"marketCap":164100248},{"date":"2023-04-28","current":-3.656798,"twenty":-7.222732,"median":-5.593482,"eighty":-2.360029,"marketCap":156715736},{"date":"2023-05-05","current":-3.876972,"twenty":-7.161437,"median":-5.593482,"eighty":-2.375693,"marketCap":166151501},{"date":"2023-05-12","current":-5.219914,"twenty":-7.141115,"median":-5.582807,"eighty":-2.377433,"marketCap":235073605},{"date":"2023-05-19","current":-5.092377,"twenty":-7.126978,"median":-5.566795,"eighty":-2.383554,"marketCap":229330096},{"date":"2023-05-26","current":-4.418252,"twenty":-7.114429,"median":-5.429439,"eighty":-2.39053,"marketCap":198971550},{"date":"2023-06-02","current":-4.554899,"twenty":-7.102566,"median":-5.219914,"eighty":-2.393967,"marketCap":205125310},{"date":"2023-06-09","current":-4.436471,"twenty":-7.097021,"median":-5.145256,"eighty":-2.397448,"marketCap":199792051},{"date":"2023-06-16","current":-5.110596,"twenty":-7.089836,"median":-5.134474,"eighty":-2.40528,"marketCap":230150597},{"date":"2023-06-23","current":-5.147036,"twenty":-7.086333,"median":-5.156037,"eighty":-2.436608,"marketCap":231791600},{"date":"2023-06-30","current":-4.381813,"twenty":-7.082799,"median":-5.134474,"eighty":-2.437538,"marketCap":197330548},{"date":"2023-07-07","current":-4.600448,"twenty":-7.064072,"median":-5.110596,"eighty":-2.437771,"marketCap":207176563},{"date":"2023-07-14","current":-5.575196,"twenty":-7.052176,"median":-5.110596,"eighty":-2.441687,"marketCap":251073379},{"date":"2023-07-21","current":-9.382079,"twenty":-7.085449,"median":-5.147036,"eighty":-2.448851,"marketCap":422512554},{"date":"2023-07-28","current":-9.253733,"twenty":-7.118052,"median":-5.210804,"eighty":-2.455753,"marketCap":416732628},{"date":"2023-08-04","current":-9.11897,"twenty":-7.240218,"median":-5.320122,"eighty":-2.463585,"marketCap":410663706},{"date":"2023-08-11","current":-8.752,"twenty":-7.404179,"median":-5.397952,"eighty":-2.467066,"marketCap":406906755},{"date":"2023-08-18","current":-7.965898,"twenty":-7.60092,"median":-5.429439,"eighty":-2.46806,"marketCap":370358476},{"date":"2023-08-25","current":-7.61739,"twenty":-7.695122,"median":-5.513668,"eighty":-2.473653,"marketCap":354155293},{"date":"2023-09-01","current":-7.492922,"twenty":-7.770568,"median":-5.575196,"eighty":-2.481859,"marketCap":348368442},{"date":"2023-09-07","current":-7.380902,"twenty":-7.767705,"median":-5.588145,"eighty":-2.487081,"marketCap":343160276},{"date":"2023-09-15","current":-6.85814,"twenty":-7.766715,"median":-5.593482,"eighty":-2.488821,"marketCap":318855501},{"date":"2023-09-22","current":-5.887296,"twenty":-7.732232,"median":-5.602525,"eighty":-2.490499,"marketCap":273718061},{"date":"2023-09-29","current":-5.19028,"twenty":-7.666847,"median":-5.593482,"eighty":-2.49255,"marketCap":241311695},{"date":"2023-10-06","current":-5.576128,"twenty":-7.637688,"median":-5.593482,"eighty":-2.494913,"marketCap":259250933},{"date":"2023-10-12","current":-5.177833,"twenty":-7.635038,"median":-5.579467,"eighty":-2.500134,"marketCap":240733009},{"date":"2023-10-20","current":-4.343904,"twenty":-7.620743,"median":-5.572132,"eighty":-2.501875,"marketCap":201961106},{"date":"2023-10-27","current":-4.007842,"twenty":-7.614901,"median":-5.561458,"eighty":-2.506226,"marketCap":186336608},{"date":"2023-11-03","current":-2.439556,"twenty":-7.6046,"median":-5.465632,"eighty":-2.494913,"marketCap":113422283},{"date":"2023-11-10","current":-2.315089,"twenty":-7.60092,"median":-5.420329,"eighty":-2.494913,"marketCap":107635432},{"date":"2023-11-17","current":-2.659529,"twenty":-7.580741,"median":-5.37478,"eighty":-2.491928,"marketCap":129625466},{"date":"2023-11-24","current":-2.815917,"twenty":-7.53696,"median":-5.352087,"eighty":-2.493172,"marketCap":137247792},{"date":"2023-12-01","current":-2.851561,"twenty":-7.510453,"median":-5.277407,"eighty":-2.501875,"marketCap":138985106},{"date":"2023-12-08","current":-3.338703,"twenty":-7.499934,"median":-5.233843,"eighty":-2.501875,"marketCap":162728395},{"date":"2023-12-15","current":-3.564452,"twenty":-7.477986,"median":-5.219914,"eighty":-2.514928,"marketCap":173731383},{"date":"2023-12-22","current":-3.754556,"twenty":-7.434321,"median":-5.195987,"eighty":-2.526809,"marketCap":182997056},{"date":"2023-12-29","current":-4.550617,"twenty":-7.40566,"median":-5.177833,"eighty":-2.530479,"marketCap":221797065},{"date":"2024-01-05","current":-4.776365,"twenty":-7.387091,"median":-5.160712,"eighty":-2.535132,"marketCap":232800053},{"date":"2024-01-12","current":-4.598143,"twenty":-7.374979,"median":-5.147036,"eighty":-2.538641,"marketCap":224113484},{"date":"2024-01-19","current":-4.372394,"twenty":-7.334851,"median":-5.132811,"eighty":-2.542883,"marketCap":213110496},{"date":"2024-01-26","current":-3.861489,"twenty":-7.296337,"median":-5.106041,"eighty":-2.547996,"marketCap":188208998},{"date":"2024-02-02","current":-3.695148,"twenty":-7.269758,"median":-5.063995,"eighty":-2.553047,"marketCap":180101533},{"date":"2024-02-09","current":-3.588215,"twenty":-7.205245,"median":-4.989418,"eighty":-2.562386,"marketCap":174889592},{"date":"2024-02-16","current":-3.718911,"twenty":-7.15702,"median":-4.86761,"eighty":-2.569752,"marketCap":181259742},{"date":"2024-02-23","current":-3.968423,"twenty":-7.141115,"median":-4.782644,"eighty":-2.574787,"marketCap":193420939},{"date":"2024-03-01","current":-5.120929,"twenty":-7.126978,"median":-4.809209,"eighty":-2.579729,"marketCap":249594086},{"date":"2024-03-08","current":-5.192218,"twenty":-7.114429,"median":-4.86761,"eighty":-2.579915,"marketCap":253068714},{"date":"2024-03-15","current":-4.859536,"twenty":-7.101574,"median":-4.916346,"eighty":-2.583683,"marketCap":236853785},{"date":"2024-03-22","current":-5.144692,"twenty":-7.095444,"median":-4.930825,"eighty":-2.589158,"marketCap":250752296},{"date":"2024-03-28","current":-4.703502,"twenty":-7.089836,"median":-4.895181,"eighty":-2.591477,"marketCap":246327089},{"date":"2024-04-05","current":-4.405231,"twenty":-7.085449,"median":-4.848419,"eighty":-2.599721,"marketCap":230706347},{"date":"2024-04-12","current":-4.462591,"twenty":-7.075967,"median":-4.782644,"eighty":-2.603221,"marketCap":233710336},{"date":"2024-04-19","current":-3.625138,"twenty":-7.052176,"median":-4.776365,"eighty":-2.611522,"marketCap":189852098},{"date":"2024-04-26","current":-3.659554,"twenty":-7.051055,"median":-4.746204,"eighty":-2.620676,"marketCap":191654491},{"date":"2024-05-03","current":-3.99224,"twenty":-7.046226,"median":-4.732967,"eighty":-2.645525,"marketCap":209077627},{"date":"2024-05-10","current":-4.095488,"twenty":-7.042536,"median":-4.709765,"eighty":-2.655033,"marketCap":214484807},{"date":"2024-05-17","current":-4.006249,"twenty":-7.031951,"median":-4.692829,"eighty":-2.658717,"marketCap":224097571},{"date":"2024-05-24","current":-3.651809,"twenty":-7.023828,"median":-4.668715,"eighty":-2.660212,"marketCap":204271245},{"date":"2024-05-31","current":-3.200703,"twenty":-7.013201,"median":-4.655071,"eighty":-2.662946,"marketCap":179037738},{"date":"2024-06-07","current":-2.674413,"twenty":-6.98883,"median":-4.622094,"eighty":-2.673339,"marketCap":149598647},{"date":"2024-06-14","current":-2.835522,"twenty":-6.957296,"median":-4.609791,"eighty":-2.674198,"marketCap":158610613},{"date":"2024-06-21","current":-2.373676,"twenty":-6.949257,"median":-4.600351,"eighty":-2.669182,"marketCap":132776309},{"date":"2024-06-28","current":-2.534785,"twenty":-6.949154,"median":-4.599198,"eighty":-2.662946,"marketCap":141788276},{"date":"2024-07-05","current":-2.545526,"twenty":-6.899852,"median":-4.564008,"eighty":-2.652004,"marketCap":142389073},{"date":"2024-07-12","current":-2.814041,"twenty":-6.88559,"median":-4.51846,"eighty":-2.608794,"marketCap":157409018},{"date":"2024-07-15","current":-3.028853,"twenty":-6.885106,"median":-4.51846,"eighty":-2.610652,"marketCap":169424973},{"date":"2024-08-02","current":-3.469219,"twenty":-6.884691,"median":-4.51846,"eighty":-2.611522,"marketCap":194057682},{"date":"2024-08-09","current":-2.942928,"twenty":-6.879299,"median":-4.495685,"eighty":-2.620676,"marketCap":164618591},{"date":"2024-08-16","current":-2.385074,"twenty":-6.863694,"median":-4.477268,"eighty":-2.603221,"marketCap":154705428},{"date":"2024-08-23","current":-2.602741,"twenty":-6.860444,"median":-4.459078,"eighty":-2.601639,"marketCap":168824176},{"date":"2024-08-30","current":-2.602741,"twenty":-6.848113,"median":-4.436471,"eighty":-2.601639,"marketCap":168824176},{"date":"2024-09-06","current":-2.10257,"twenty":-6.808005,"median":-4.418252,"eighty":-2.589519,"marketCap":136381096},{"date":"2024-09-13","current":-2.269294,"twenty":-6.789035,"median":-4.418252,"eighty":-2.579729,"marketCap":147195456},{"date":"2024-09-20","current":-2.389705,"twenty":-6.77836,"median":-4.405231,"eighty":-2.565691,"marketCap":155005827},{"date":"2024-09-27","current":-2.250769,"twenty":-6.772661,"median":-4.391706,"eighty":-2.545526,"marketCap":145993860},{"date":"2024-10-04","current":-2.213719,"twenty":-6.763825,"median":-4.381813,"eighty":-2.537904,"marketCap":143590669},{"date":"2024-10-11","current":-2.084045,"twenty":-6.75499,"median":-4.351551,"eighty":-2.52363,"marketCap":135179500},{"date":"2024-10-18","current":-2.463804,"twenty":-6.75036,"median":-4.324868,"eighty":-2.493172,"marketCap":159812209},{"date":"2024-10-25","current":-2.537904,"twenty":-6.746336,"median":-4.303834,"eighty":-2.493172,"marketCap":164618591},{"date":"2024-10-31","current":-2.806514,"twenty":-6.74619,"median":-4.290341,"eighty":-2.499318,"marketCap":182041727},{"date":"2024-11-08","current":-2.936188,"twenty":-6.746154,"median":-4.256095,"eighty":-2.501671,"marketCap":190452896},{"date":"2024-11-15","current":-1.919975,"twenty":-6.744338,"median":-4.235757,"eighty":-2.492861,"marketCap":156808220},{"date":"2024-11-22","current":-1.699288,"twenty":-6.743884,"median":-4.184437,"eighty":-2.487273,"marketCap":138784287},{"date":"2024-11-29","current":-1.669864,"twenty":-6.738951,"median":-4.141738,"eighty":-2.476886,"marketCap":136381096},{"date":"2024-12-06","current":-1.55952,"twenty":-6.732888,"median":-4.12513,"eighty":-2.463368,"marketCap":127369129},{"date":"2024-12-13","current":-1.522739,"twenty":-6.729504,"median":-4.092174,"eighty":-2.444359,"marketCap":124365140},{"date":"2024-12-20","current":-1.324121,"twenty":-6.714601,"median":-4.072455,"eighty":-2.437306,"marketCap":108143600},{"date":"2024-12-27","current":-1.390327,"twenty":-6.700464,"median":-4.039868,"eighty":-2.401761,"marketCap":113550780},{"date":"2025-01-03","current":-1.360902,"twenty":-6.686699,"median":-4.021508,"eighty":-2.390383,"marketCap":111147589},{"date":"2025-01-10","current":-1.250559,"twenty":-6.66094,"median":-4.007046,"eighty":-2.380443,"marketCap":102135622},{"date":"2025-01-17","current":-1.184353,"twenty":-6.644542,"median":-4.002969,"eighty":-2.373676,"marketCap":96728442},{"date":"2025-01-24","current":-1.272627,"twenty":-6.614962,"median":-3.980769,"eighty":-2.352041,"marketCap":103938015},{"date":"2025-01-31","current":-1.147571,"twenty":-6.580597,"median":-3.965855,"eighty":-2.338607,"marketCap":93724453},{"date":"2025-02-07","current":-1.081365,"twenty":-6.566786,"median":-3.94466,"eighty":-2.323016,"marketCap":88317273},{"date":"2025-02-14","current":-1.074009,"twenty":-6.564899,"median":-3.918151,"eighty":-2.312943,"marketCap":87716475},{"date":"2025-02-21","current":-1.015159,"twenty":-6.562308,"median":-3.912497,"eighty":-2.301318,"marketCap":82910093},{"date":"2025-02-28","current":-0.926885,"twenty":-6.560601,"median":-3.900465,"eighty":-2.293717,"marketCap":75700520},{"date":"2025-03-07","current":-0.912172,"twenty":-6.556757,"median":-3.891331,"eighty":-2.270478,"marketCap":74498924},{"date":"2025-03-14","current":-0.89746,"twenty":-6.544785,"median":-3.876972,"eighty":-2.264162,"marketCap":73297329},{"date":"2025-03-21","current":-0.868035,"twenty":-6.535112,"median":-3.858033,"eighty":-2.256474,"marketCap":70894138},{"date":"2025-03-28","current":-0.728096,"twenty":-6.530944,"median":-3.854577,"eighty":-2.230367,"marketCap":74505312},{"date":"2025-04-04","current":-0.584844,"twenty":-6.525172,"median":-3.844144,"eighty":-2.213719,"marketCap":59846543},{"date":"2025-04-11","current":-0.603787,"twenty":-6.521372,"median":-3.829108,"eighty":-2.194295,"marketCap":61784893},{"date":"2025-04-17","current":-0.580109,"twenty":-6.515538,"median":-3.829108,"eighty":-2.181634,"marketCap":59361956}],"updateTime":1745255315813}}}